Home
GSC Advanced Research and Reviews
Peer-reviewed | Multidisciplinary Journal | Impact factor 8.3 | ISSN: 2582-4597 | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Pharmacotherapeutic effect of methanolic and ethanolic extract of Spinacia oleracea L. leaves on glycemic and lipidemic indexes of alloxan-induced diabetic mice

Breadcrumb

  • Home
  • Pharmacotherapeutic Effect of Methanolic and Ethanolic Extract of Spinacia Oleracea L. Leaves On Glycemic and Lipidemic Indexes of Alloxan-induced Diabetic Mice
  • Pharmacotherapeutic effect of methanolic and ethanolic extract of Spinacia oleracea L. leaves on glycemic and lipidemic indexes of alloxan-induced diabetic mice

Shahanaz Khatun * and Mst. Khadiza Khatun

Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi-6205, Bangladesh.
 
GSC Advanced Research and Reviews, 2023, 16(03), 188–195.
Article DOI: 10.30574/gscarr.2023.16.3.0362
DOI url: https://doi.org/10.30574/gscarr.2023.16.3.0362
With the various side effects associated with synthetic medicines for treating diabetes, there is a need to develop herbal remedies as an alternative. Although Spinacia oleracea L. leaves are used to treat various health conditions, including diabetes, there is little research to validate its antidiabetic properties. This study aimed to investigate the hypoglycemic and hypolipidemic effect of methanolic and ethanolic extracts of Spinacia oleracea L. leaves against alloxan-induced hyperglycemia in mice. Hyperglycemia was induced by an injection of alloxan monohydrate 80mg/kg bw. (i.p.). After 72 hours, mice with Blood Glucose Levels above 11.0 mmol/L were selected for the investigation. Both methanolic and ethanolic extracts at 200 mg/kg bw. doses were observed to have antidiabetic effect for 21 consecutive days. Blood Glucose Level was monitored after 3, 6, 9, 12, 15, 18, and 21 days and compared with Glibenclamide (0.5 mg/kg b.wt.). Serum lipid profile [total cholesterol, triglycerides, low-density lipoprotein, and high-density lipoprotein] and liver enzymes such as SGPT, and SGOT were also determined. Oral administration of both extracts showed significant (P < 0.05) antihyperglycemic activity in alloxan-induced diabetic mice. The diabetic mice had significant (P < 0.01) reduction in blood glucose; serum liver enzyme level (SGPT and SGOT) and lipid profile were compared with normal mice.
 

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 GSC Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution